Will the new entity Truist, resulting from the merger of SunTrust and BB&T, appeal to customers and investors shaken by banking scandals? Read More
Jim Pearce is the Chief Investment Strategist of Personal Finance, our flagship publication, and manages two trading services, PF Pro and Mayhem Trader. He began his career as a stockbroker in 1983 and over the years has managed client investment portfolios for major banks, brokerage firms, and investment advisors. Jim earned a BA from The College of William & Mary and the CFP designation from the College of Financial Planning.
Analyst Articles
We added global health care conglomerate Johnson & Johnson (NYSE: JNJ) to our Growth Portfolio eight years ago. Since then, it has returned more than 160% in dividends and share price appreciation. However, JNJ has been stagnant for the past eighteen months, slightly worse than the overall stock market. Weighing… Read More
A new law says the best interests of the client must supersede the financial interests of the person making the recommendation. Read More
Can this food company sustain momentum and dominate its market, or will competitors come along to eat its lunch? Read More
I have learned many valuable lessons about investing over the past four decades, but these three stand out as the most important. Read More
None of the top 10 companies in 2018 for revenues or profits were among the best performing stocks in 2018. Here are the lessons for investors. Read More
In response to new U.S. tariffs, China is threatening to restrict access to precious metals that many industries can't live without. Read More
The tariff slugfest with China won’t go on forever, and when it ends these three companies should rally strongly. Read More
The unintended consequences of approving medical marijuana in France could be considerably larger than in the U.S. or Canada. Read More
Any one of these red flags could strongly indicate that your investment is at risk of blowing up. Read More